
Onychomycosis is a common infection of the fingernails and toenails caused by naturally occurring skin fungi. Mechanical pressure (such as tight shoes) and advancing age make the nails more prone to infection. Not only does the nail become infected, but the nail bed beneath the skin is also diseased. As a result, topical medications such as creams are not effective. Involved nails are usually deformed and discolored as a result. The poor appearance of these nails causes many people to seek treatment. Oral antifungal medications have been widely advertised lately as treatment for onychomycosis. The reasons for this are twofold:
The two medications approved for treatment by the FDA are Sporanox
(itraconazole) and Lamisil (terfenabine). Sporanox is taken either
daily or twice a day for a week, followed by a 3 week pause; Lamisil
is taken daily. Both medications are prescribed for a 3 month
course. Potential side effects of Sporanox and Lamisil include
gastrointestinal upset, liver damage, headache, fever, dizziness,
ankle swelling, decreased blood potassium levels, rash, and hives.
Sporanox has serious interactions with over one dozen different
medications including potentially life-threatening heart arrhythmias
when taken in conjunction with Propulsid (cisapride) or Hismanal
(astemizole). Periodic blood tests for liver function testing
are recommended when medications are taken daily.
Results of controlled trials to evaluate these medications have
shown that at best they work 50% of the time. Recurrence
of onychomycosis after treatment may occur. Toenail fungus is
usually considered a cosmetic, rather than a medical problem,
and is generally not covered by health plans. A 3 month course
of therapy costs $300-$500.
If you wish to take medications for onychomycosis, we ask that
you weigh the cost, risks, and benefits of treatment with antifungal
regimens. At this time, since treatment is both expensive and
relatively ineffective, we physicians at General Internal Medicine
are reluctant to prescribe these medications.